Stock screener

TBPH

Conviction 44HealthcareScan · Thu, Sep 24, 2026

Theravance Biopharma, Inc. (TBPH) closed at $17.03 (+0.00%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 53, RS Rating 77, -17.9% from its 52-week high, -6.2% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

TBPH$17.03+0.00%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
3
Vol MA14 1.48M
Jun 25Jul 14Jul 31Aug 18Sep 4Sep 23
Theravance Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.theravance.com ↗
Price17.03
Change+0.00%
Gap+0.18%
Rel volume14.41×
Avg volume1.18M
Avg $ vol20.14M
SMA 2017.04
SMA 5016.96
SMA 20017.18
Price vs 50+0.39%
Price vs 200-0.87%
MA stackmixed
50/200 cross—
Supertrendup · 16.95
RSI (14)53
MACD hist-0.01
MACD crossbear · 9d
Stoch %K / %D12 / 14
ADX (14)41
+DI / −DI25 / 10
RSI divergence—
MACD divergence—
ATR %0.33%
ADR %0.30%
52w high20.74
52w low13.57
From 52w high-17.89%
Above 52w low+25.50%
New 52w highNo
SqueezeOn · 42d
Bollinger width0.45%
%B0.34
Donchian pos11.76%
Donchian high17.26
Donchian low17.00
AVWAP (52w high)16.65
vs AVWAP high+2.28%
AVWAP (52w low)16.30
vs AVWAP low+4.48%
OBV trendDown
Chaikin MF (20)-0.60
Today vs 20d14.41×
Avg vol (14d)1.48M
Avg vol (20d)1.18M
Avg $ vol (20d)20.14M
Market cap884.18M
RS Rating77 / 99
RS 3m (vs SPY)-6.10%
RS 6m (vs SPY)-3.25%
RS line new highNo
Trend template2/8
Technical rank62.8
1 week+0.00%
1 month+0.12%
3 months-1.39%
6 months+14.30%
1 year+21.04%
YTD-6.17%
P/E8.35
P/B3.05
P/S8.23
P/FCF3.74
EPS2.06
Div yield—
ROE36.55%
ROA22.54%
Debt/Eq0.00
Current13.54
EV/EBITDA—
Gross margin—
Net margin98.54%
Rev growth66.92%
EPS growth287.70%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value664.41M
Revenue20.73M
Net income-5.9M
Gross profit—
Free cash flow236.41M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out51.55M
Employees90
ListedFri, May 16, 2014
Free float46.92M
Float %92.6%
Short interest1.62M
Days to cover4.5d
Short volume—
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank62.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance17.14
Support16.88
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in TBPH · 1 recent

All disclosures →
MemberSideAmount
George Whitesides
George Whitesides
house · D · CA · traded 2025-03-24
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in TBPH · open-market 5 sells

InsiderSideShares
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS · Ordinary Shares · 2026-09-15
Sell6.66K
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS · Ordinary Shares · 2026-09-15
Sell3.33K
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS · Ordinary Shares · 2026-09-15
Sell3.33K
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER · Ordinary Shares · 2026-08-20
Tax8.11K
Winningham Rick E
CHIEF EXECUTIVE OFFICER · Ordinary Shares · 2026-08-20
Tax20.03K
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY · Ordinary Shares · 2026-08-20
Tax7.95K
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS · Ordinary Shares · 2026-08-20
Tax5.67K
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE · Ordinary Shares · 2026-08-20
Tax6.26K
Samaha Eli
10% owner · COM · 2026-07-07
Sell5.56K
Samaha Eli
10% owner · COM · 2026-07-06
Sell1.4K

SEC filings

EDGAR filings in TBPH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.